Entrada Therapeutics Inc (TRDA)

Entrada Therapeutics Inc (TRDA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $209M; returns 1 day -6.8%, 1 week +0.9%, 1 year -31.1%.

Entrada Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on transforming the lives of patients by developing a new class of medicines that engage previously inaccessible intracellular targets.

Groups TRDA belongs to

• Biotechnology
• Clinical Stage Biotech
• Duchenne Muscular Dystrophy
• Exon Skipping
• Clinical Stage
• Healthcare
• Biopharmaceutical
• Rare Diseases
• Life Sciences
• Precision Medicine

TRDA financial model: income statement, cash flow and balance sheet